11:21 AM EST - Epicore BioNetworks : reported for the quarter ended December 31, 2014, in U.S. dollars, Revenue for Q2 at $2.4 million was 45% higher than last year's Q2 and set a new company Q2 record. Net income decreased by 11% versus last year's Q2 to $284,000. Epicore BioNetworks
shares V.EBN are trading unchanged at $0.88.
